IMU-201 (PD1-Vaxx) clinical trials

A study to test the effectiveness of a vaccine targeting a protein that hides cancer cells from the body's immune system in operable colorectal cancer that has defective mismatch repair

This study tests a new vaccine for a certain type of bowel cancer before surgery. It aims to see if the vaccine can help your body's immune system fight the cancer and how well it works in people whose cancer has specific genetic changes.